The report "Electrosurgery Market by Product (Instruments, Accessories, Generators, Smoke Evacuation Systems), Surgery (Cardiovascular, Orthopedic, Cosmetic, Oncology, Urology, Neurosurgery), End User (Hospitals, Ambulatory Surgical Centers): Global Forecast to 2031" is projected to grow from USD 8.01 billion in 2025 and to reach USD 11.59 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period.

Browse 250 market data Tables and 50 Figures spread through 300 Pages and in-depth TOC on "Electrosurgery Market by Product (Instruments, Accessories, Generators, Smoke Evacuation Systems), Surgery (Cardiovascular, Orthopedic, Cosmetic, Oncology, Urology, Neurosurgery), End User (Hospitals, Ambulatory Surgical Centers): Global Forecast to 2031"

Download PDF- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142006761

The rise in chronic diseases such as cancer, cardiovascular disorders, and gastrointestinal conditions, which leads to a substantial increase in surgical procedures, is one of the major factors driving the electrosurgery market. The increasing preference for minimally invasive surgeries is further stimulating market growth. Additionally, innovation and technological breakthroughs, such as sophisticated energy-based platforms and improved tissue control, are making surgical procedures safer and more efficient. Moreover, demand for electrosurgical systems is further stimulated by the rising inclination toward outpatient and day care surgeries in developed regions. This is because such procedures call for efficient, reliable, and cost-effective surgical technologies not only in hospitals but also in ambulatory surgical centers.

“In 2024, bipolar electrosurgical instruments accounted for the largest share by type of electrosurgical instrument in the electrosurgery market.”

Within the electrosurgery market, products include electrosurgical generators, electrosurgical instruments, electrosurgical accessories, and smoke evacuation systems. In 2024, electrosurgical instruments held the largest share of the market. This segment is further divided into monopolar and bipolar electrosurgical instruments based on the electrode used. Among these, bipolar electrosurgical instruments held the largest share. This is due to their superior vessel-sealing capability, enhanced safety profile, and growing adoption across complex surgical procedures. These instruments enable effective sealing of larger vessels, up to 5 mm in diameter, compared with monopolar devices, reducing intraoperative bleeding and improving procedural outcomes. Technological advancements, including high-current energy delivery and thermo-fusion technology, have further improved precision and reliability. Lower power requirements limit unintended thermal spread, enhancing patient safety and surgeon confidence. Additionally, the availability of advanced vessel-sealing instruments and bipolar forceps supports broad clinical application, reinforcing the segment’s dominant market position.

“The general surgery segment accounted for the largest share of the Electrosurgery market by surgical procedure in 2024.”

By surgical specialty, the electrosurgery market includes segments such as general surgery, obstetric/gynecological surgery, urological surgery, orthopedic surgery, cardiovascular surgery, cosmetic surgery, neurosurgery, oncological surgery, and other surgical procedures. In 2024, the general surgery segment accounted for the largest share of the market. This is due to the rising prevalence of chronic diseases such as obesity and gastrointestinal disorders, which have significantly increased the number of general surgical procedures worldwide. For instance, according to the World Obesity Federation, in 2024 there were more than 1 billion people living with obesity worldwide. Additionally, electrosurgical products are used in general surgery for tissue dissection, coagulation, and hemostasis, offering surgeons enhanced precision, control, and operational efficiency. Moreover, their ability to support minimally invasive techniques, reduce blood loss, and shorten procedure times further strengthens adoption.

“The Asia Pacific region is anticipated to experience the most rapid growth throughout the forecast period.”

Segmented by region, the electrosurgery market includes North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific region is expected to exhibit the highest growth rate and record the highest CAGR during the forecast period. This is mainly attributed to the region's large and rapidly aging population, escalating burden of chronic diseases, and widening access to healthcare services. For instance, according to the United Nations Population Fund (UNFPA) report on Asia and the Pacific, by 2050, 1 out of every 4 persons in the region will be aged 60 or over, and the elderly population is expected to triple from 2010 to 2050 to reach nearly 1.3 billion. This shift in the aging population is largely contributing to increased demand for surgical procedures, which in turn depend on electrosurgical products such as electrosurgical generators and instruments. Moreover, increasing healthcare expenditure and government funding for hospital infrastructure in emerging market economies are contributing to market growth.

Key Market Players

The key players in the electrosurgery market include Medtronic plc (Ireland), Johnson & Johnson (Ethicon) (US), Olympus Corporation (Japan), B. Braun SE (Germany), CONMED Corporation (US), Boston Scientific Corporation (US), Smith and Nephew Plc (UK), Erbe Elektromedizin GmbH (Germany), BOWA-electronic GmbH & Co. KG (Germany), The Cooper Companies, Inc. (US), Zimmer Biomet (US), Stryker Corporation (US), and other players.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.